STOCK TITAN

Happiness Biotech Starts Offering Kingdomway Coenzyme Q10 in Its Experience Stores

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Happiness Biotech Group Limited (Nasdaq: HAPP) has launched Coenzyme Q10, a product sourced from Xiamen Kingdomway Group, in its 26 experience stores across China. Coenzyme Q10 is known for its potential health benefits, including aiding conditions such as diabetes and Alzheimer's. The CEO highlighted that this addition enhances market influence and sales performance while aiming to diversify the product range. Happiness Biotech, founded to produce high-quality nutraceuticals, currently holds 32 registered nutraceutical SKUs in China.

Positive
  • Introduction of Coenzyme Q10 enhances product offerings and sales potential.
  • Expansion of experience stores to 26 locations increases market presence.
  • Collaboration with KDW, the largest global Coenzyme Q10 manufacturer, strengthens product credibility.
Negative
  • None.

NANPING, China, Nov. 16, 2020 /PRNewswire/ -- Happiness Biotech Group Limited (the "Company" or Nasdaq: HAPP), an innovative China-based nutraceutical and dietary supplements producer, announced today that the Company's experience stores started offering Coenzyme Q10 - a best-selling product from Xiamen Kingdomway Group Company ("KDW", SZSE: 002626).

Coenzyme Q10 is a vitamin-like substance that is produced naturally by the human body. Research suggests coenzyme Q10 may help treat or prevent disease ranging from diabetes,migraines to Alzheimer's disease, as well as slow signs of aging. KDW, founded in 1997, is the world's largest manufacturer of coenzyme Q10. KDW is currently publicly listed on the Shenzhen Stock Exchange.

"Coenzyme Q10 Capsule is one of the most popular nutrition supplement products in China. At present, we have 26 experience stores all over China and formed a certain scale effect. Adding Coenzyme Q10 Capsule in our product offerings brings greater market influence and sales volume to our experience stores. This is just a beginning of our plan to further diversify our product series and improve the sales performance of the stores," said Mr. Xuezhu Wang, CEO of the Company.

About Happiness Biotech Group Limited

Headquartered in Nanping, China, Happiness Biotech Group Limited is an innovative China-based nutraceutical and dietary supplements producer focused on the research, development, manufacturing and marketing of a variety of products made from Chinese herbal extracts and other ingredients. The Company's goal is to provide high-quality products to our consumers. Over the past 14 years, the Company has established a product portfolio consisting of 32 PRC National Medical Products Administration registered "Blue-Cap" SKUs of nutraceutical and dietary supplements products. For more information, please visit: www.happ.org.cn.

Forward-Looking Statements

This press release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. When the Company uses words such as "may, "will, "intend," "should," "believe," "expect," "anticipate," "project," "estimate" or similar expressions that do not relate solely to historical matters, it is making forward-looking statements. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that may cause the actual results to differ materially from the Company's expectations discussed in the forward-looking statements. These statements are subject to uncertainties and risks including, but not limited to, the following:  the Company's goals and strategies; the Company's future business development; product and service demand and acceptance; changes in technology; economic conditions; reputation and brand; the impact of competition and pricing; government regulations; fluctuations in general economic and business conditions in China, the COVID-19 outbreak and its impact on our operations and assumptions underlying or related to any of the foregoing and other risks contained in reports filed by the Company with the Securities and Exchange Commission.  For these reasons, among others, investors are cautioned not to place undue reliance upon any forward-looking statements in this press release. Additional factors are discussed in the Company's filings with the U.S. Securities and Exchange Commission, which are available for review at www.sec.gov. The Company undertakes no obligation to publicly revise these forward-looking statements to reflect events or circumstances that arise after the date hereof.

Cision View original content:http://www.prnewswire.com/news-releases/happiness-biotech-starts-offering-kingdomway-coenzyme-q10-in-its-experience-stores-301173452.html

SOURCE Happiness Biotech Group Limited

FAQ

What new product did Happiness Biotech (HAPP) launch?

Happiness Biotech launched Coenzyme Q10 in its experience stores.

How many experience stores does Happiness Biotech (HAPP) have?

Happiness Biotech currently operates 26 experience stores across China.

Who manufactures the Coenzyme Q10 offered by Happiness Biotech (HAPP)?

The Coenzyme Q10 is sourced from Xiamen Kingdomway Group, the largest manufacturer of the product.

What are the potential benefits of Coenzyme Q10?

Coenzyme Q10 may help in treating or preventing conditions such as diabetes, migraines, and Alzheimer's disease.

What is the growth strategy of Happiness Biotech (HAPP)?

The company aims to diversify its product series to enhance sales performance.

HAPP

:HAPP

HAPP Rankings

HAPP Latest News

HAPP Stock Data

31.30M
3.60M
0.11%
0.76%
0.2%
Packaged Foods
Consumer Defensive
Link
China
Nanping